mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.41 |
0.1 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.28 |
0.4 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.22 |
0.5 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.01 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.08 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.002 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.001 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.1 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.1 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |